Advertisement

Evaluation of the GABAergic nervous system in autistic brain: 123I-iomazenil SPECT study

Published:November 18, 2011DOI:https://doi.org/10.1016/j.braindev.2011.10.007

      Abstract

      Purpose

      To evaluate the GABAA receptor in the autistic brain, we performed 123I-IMZ SPECT in patients with ASD. We compared 123I-IMZ SPECT abnormalities in patients who showed intellectual disturbance or focal epileptic discharge on EEG to those in patients without such findings.

      Subjects and methods

      The subjects consisted of 24 patients with ASD (mean age, 7.3 ± 3.5 years), including 9 with autistic disorder (mean age, 7.0 ± 3.7 years) and 15 with Asperger’s disorder (mean age, 7.5 ± 3.2 years). We used 10 non-symptomatic partial epilepsy patients (mean age, 7.8 ± 3.6 years) without intellectual delay as a control group.
      For an objective evaluation of the 123I-IMZ SPECT results, we performed an SEE (Stereotactic Extraction Estimation) analysis to describe the decrease in accumulation in each brain lobule numerically.

      Results

      In the comparison of the ASD group and the control group, there was a dramatic decrease in the accumulation of 123I-IMZ in the superior and medial frontal cortex. In the group with intellectual impairment and focal epileptic discharge on EEG, the decrease in accumulation in the superior and medial frontal cortex was greater than that in the group without these findings.

      Conclusion

      The present results suggest that disturbance of the GABAergic nervous system may contribute to the pathophysiology and aggravation of ASD, since the accumulation of 123I-IMZ was decreased in the superior and medial frontal cortex, which is considered to be associated with inference of the thoughts, feelings, and intentions of others (Theory of Mind).

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bailey A.
        • Le Couteur A.
        • Gottesman I.
        • Bolton P.
        • Simonoff E.
        • Yuzda E.
        • et al.
        Autism as a strongly genetic disorder: evidence from a British twin study.
        Psychol Med. 1995; 25: 63-77
        • Descheemaeker M.J.
        • Govers V.
        • Vermeulen P.
        • Fryns J.P.
        Pervasive developmental disorders in Prader–Willi syndrome: the Leuven experience in 59 subjects and controls.
        Am J Med Genet A. 2006; 140: 1136-1142
        • Scambler D.J.
        • Hepburn S.L.
        • Hagerman R.J.
        • Rogers S.J.
        A preliminary study of screening for risk of autism in children with fragile X syndrome: testing two risk cut-offs for the Checklist for Autism in Toddlers.
        J Intellect Disabil Res. 2007; 51: 269-276
        • Simon J.
        • Wakimoto H.
        • Fujita N.
        • Lalande M.
        • Barnard E.A.
        Analysis of the set of GABA(A) receptor genes in the human genome.
        J Biol Chem. 2004; 279: 41422-41435
        • Cook Jr., E.H.
        • Courchesne R.Y.
        • Cox N.J.
        • Lord C.
        • Gonen D.
        • Guter S.J.
        • et al.
        Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers.
        Am J Hum Genet. 1998; 62: 1077-1083
        • Gantois I.
        • Vandesompele J.
        • Speleman F.
        • Reyniers E.
        • D’Hooge R.
        • Severijnen L.A.
        • et al.
        Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model.
        Neurobiol Dis. 2006; 21: 346-357
        • Fatemi S.H.
        • Reutiman T.J.
        • Folsom T.D.
        • Thuras P.D.
        GABA(A) receptor downregulation in brains of subjects with autism.
        J Autism Dev Disord. 2009; 39: 223-230
        • Oblak A.L.
        • Gibbs T.T.
        • Blatt G.J.
        Reduced GABA(A) receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism.
        Brain Res. 2010; 1380: 218-228
        • Hashimoto T.
        • Sasaki M.
        • Sugai K.
        • Hanaoka S.
        • Fukumizu M.
        • Kato T.
        Paroxysmal discharges on EEG in young autistic patients are frequent in frontal regions.
        J Med Invest. 2001; 48: 175-180
        • Onishi Y.
        • Yonekura Y.
        • Tanaka F.
        • Nishizawa S.
        • Okazawa H.
        • Ishizu K.
        • et al.
        Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding: the optimal scan time.
        Eur J Nucl Med. 1996; 23: 1491-1497
        • Minoshima S.
        • Frey K.A.
        • Koeppe R.A.
        • Foster N.L.
        • Kuhl D.E.
        A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.
        J Nucl Med. 1995; 36: 1238-1248
        • Matsui H.
        • Udaka F.
        • Miyoshi T.
        • Hara N.
        • Tamura A.
        • Oda M.
        • et al.
        Three-dimensional stereotactic surface projection study of orthostatic hypotension and brain perfusion image in Parkinson’s disease.
        Acta Neurol Scand. 2005; 112: 36-41
        • Mizumura S.
        • Kumita S.
        • Cho K.
        • Ishihara M.
        • Nakajo H.
        • Toba M.
        • et al.
        Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation.
        Ann Nucl Med. 2003; 17: 289-295
        • Ribak C.E.
        • Harris A.B.
        • Vaughn J.E.
        • Roberts E.
        Inhibitory, GABAergic nerve terminals decrease at sites of focal epilepsy.
        Science. 1979; 205: 211-214
        • Savic I.
        • Persson A.
        • Roland P.
        • Pauli S.
        • Sedvall G.
        • Widén L.
        In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci.
        Lancet. 1988; 2: 863-866
        • Johnson E.W.
        • Woods S.W.
        • Zoghbi S.
        • McBride B.J.
        • Baldwin R.M.
        • Innis R.B.
        Receptor binding characterization of the benzodiazepine radioligand 125I-Ro16-0154: potential probe for SPECT brain imaging.
        Life Sci. 1990; 47: 1535-1546
        • Hommer D.W.
        • Skolnick P.
        • Paul S.M.
        The benzodiazepine/GABA receptor complex and anxiety.
        in: Meltzer H.Y. Psychopharmacology: The Third Generation of Progress. Raven Press, New York1987: 977-983
        • Sjöholm H.
        • Rosén I.
        • Elmqvist D.
        Role of I-123-iomazenil SPECT imaging in drug-resistant epilepsy with complex partial seizures.
        Acta Neurol Scand. 1995; 92: 41-48
        • Chugani D.C.
        • Muzik O.
        • Juhász C.
        • Janisse J.J.
        • Ager J.
        • Chugani H.T.
        Postnatal maturation of human GABAA receptors measured with positron emission tomography.
        Ann Neurol. 2001; 49: 618-626
        • Blair R.J.
        Responding to the emotions of others: dissociating forms of empathy through the study of typical and psychiatric populations.
        Conscious Cogn. 2005; 14: 698-718
        • Wang A.T.
        • Lee S.S.
        • Sigman M.
        • Dapretto M.
        Reading affect in the face and voice: neural correlates of interpreting communicative intent in children and adolescents with autism spectrum disorders.
        Arch Gen Psychiatry. 2007; 64: 698-708
        • Fletcher P.C.
        • Happé F.
        • Frith U.
        • Baker S.C.
        • Dolan R.J.
        • Frackowiak R.S.
        • et al.
        Other minds in the brain: a functional imaging study of “theory of mind” in story comprehension.
        Cognition. 1995; 57: 109-128
        • Happé F.
        • Ehlers S.
        • Fletcher P.
        • Frith U.
        • Johansson M.
        • Gillberg C.
        • et al.
        ‘Theory of mind’ in the brain. Evidence from a PET scan study of Asperger syndrome.
        Neuroreport. 1996; 8: 197-201